Picture of Xvivo Perfusion AB logo

XVIVO — Xvivo Perfusion AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMid CapFalling Star

Brief: Xvivo Perfusion: Positive Findings In PrimECC Study

May 14 (Reuters) - XVIVO PERFUSION AB  XVIVO.ST :
    * POSITIVE FINDINGS IN THE PRIMECC STUDY
    * STUDY RESULTS ARE PLANNED TO GENERATE FOUR SCIENTIFIC
ARTICLES
    * ANALYSIS OF RESULTS SHOWS THAT PRODUCT IS SAFE AND
INDICATES
INTERESTING FINDINGS REGARDING DECREASED SIDE EFFECTS WHEN USING
PRIMECC

Source text for Eikon:  ID:nWkr8M1WyR 
Further company coverage:  XVIVO.ST 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 587720920;))

Recent news on Xvivo Perfusion AB

See all news